Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 27 ... induction upon stimulation with proinflammatory molecules, such as MCP-1, IL-1 beta, tumour necrosis factor a and lipopolysaccharide.""Here we show that the induction ...
2009 NOV 24 ... According to a study from London, the United Kingdom, "The tumour suppressor PTEN can inhibit cell proliferation and migration as well as control cell ...
2009 NOV 24 ... Libyan Arab Jamahiriya between 1991 and 2007 were analysed. Keratocystic odontogenic tumour (35.1%) was the most common. Among the non-odontogenic tumours, there were 85 cases of ...
2009 NOV 23 ... the severity of arthritis and histopathological findings in CIA mice. The expression of tumour necrosis factor alpha, IL-1b, IL-6, matrix metalloproteinase 3, cyclooxygenase 2 and ...
2009 NOV 27 ... and Nuclear Chemistry (Determination of calibration curves for I-131 in thyroid tumour metabolic radiotherapy and other radionuclides used in SPECT imaging. Journal of ...
2009 NOV 23 ... two clinical trial populations treated with non-steroidal anti-inflammatory drugs and tumour necrosis factor alpha inhibitors." "Sensitivity to change was assessed by ...
2009 NOV 23 ... factor in affecting the false-negative rate (p=0.019). For upper, outer quadrant tumour, five (32.3%, out of 16) patients presented with false-negative. Patients with more ...
2009 NOV 23 ... variables in patients with ankylosing spondylitis (AS) selected for eligibility for anti-tumour necrosis factor therapy. In a 6-week open-label study, 22 patients with AS and eligible ...
2009 NOV 25 ... with severe defects of the alveolar ridge of the mandible or maxilla caused by trauma, tumour resection, atrophy or partial loss of premaxilla, reconstruction was performed using six ...
2009 NOV 23 ... and the tumours presented at an advanced clinical stage. HPV was not detected in any tumour, not even in two patients with coexisting HPV-associated gynaecological neoplasm. ...
2009 NOV 23 ... was used to study the expression of TLR3, TLR7, interferon alpha (IFN alpha), tumour necrosis factor alpha (TNF alpha) and interleukins IL1 beta, IL12, IL17 and IL18 in RA ...
2009 NOV 27 ... or under clinical trial. Their impressive success is limited by the onset of resistant tumour cells during the treatment, so new resistance-proof molecules need to be developed. Here ...
2009 NOV 23 ... According to recent research from Netherlands, "Tumour necrosis factor alpha (TNF alpha) neutralising antibody constructs are increasingly ...
2009 NOV 23 ... efficacy of abatacept in patients with rheumatoid arthritis ( RA) who had failed anti-tumour necrosis factor (TNF) therapy and were switched to abatacept directly or after ...
2009 NOV 23 ... associated with a higher rate of systolic BP more than 125 mmHg during sleep time. Tumour necrosis factor alpha concentrations increased significantly during night shift (0.76 ...
2009 NOV 23 ... lymph node metastases of unknown origin: HPV-typing identifies the primary tumour,' is the subject of a report. According to a study from Kiel, Germany, "Cancers of ...
2009 NOV 23 ... results in protection from cancer. Both inflammation and IGF-1 pathway converge on the tumour suppressor p53. Accordingly, some studies indicate that genetic variants of p53 are ...
2009 NOV 23 ... following nephrectomy implying a relationship with kidney removal per se rather than tumour removal," wrote S.H. Sim and colleagues, St. James University. The ...
2009 NOV 23 ... Scientists discuss in 'Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study ...
2009 NOV 24 ... upper airway dilator muscle, were studied in rats with a growth hormone (GH)-secreting tumour (GH tumour group; n=10). The effects of muscle fatigue ...
